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Autotaxin (ATX or ENPP2) is a secreted glycosylated mammalian enzyme that
exhibits lysophospholipase D activity, hydrolyzing lysophosphatidylcholine to
the signalling lipid lysophosphatidic acid. ATX is an  100 kDa multi-domain
protein encompassing two N-terminal somatomedin B-like domains, a central
catalytic phosphodiesterase domain and a C-terminal nuclease-like domain.
Protocols for the efﬁcient expression of ATX from stably transfected
mammalian HEK293 cells in amounts sufﬁcient for crystallographic studies
are reported. Puriﬁcation resulted in protein that crystallized readily, but various
attempts to grow crystals suitable in size for routine crystallographic structure
determination were not successful. However, the available micrometre-thick
plates diffracted X-rays beyond 2.0 A ˚ resolution and allowed the collection of
complete diffraction data to about 2.6 A ˚ resolution. The problems encountered
and the current advantages and limitations of diffraction data collection from
thin crystal plates are discussed.
1. Introduction
Autotaxin (ATX), the second member of the ectonucleotide phos-
phodiesterase/pyrophosphatase(ENPP)family,isasecreted 100 kDa
glycoprotein (Stracke et al., 1992). ATX/ENPP2 is classiﬁed as a
phosphoric diester hydrolase (EC 3.1.4.–) that displays alkylglycero-
phosphoethanolamine phosphodiesterase (lysophospholipase D)
activity (Umezu-Goto et al., 2002; EC 3.1.4.39). Autotaxin converts
extracellular lysophosphatidylcholine (LPC) to lysophosphatidic acid
(LPA), a signalling phospholipid that acts on at least six distinct
G-protein-coupled receptors (LPA1–6) and elicits a great variety of
both short-term and long-term cellular responses (van Meeteren &
Moolenaar, 2007). ATX and LPA signalling have been strongly
implicated in tumour progression and metastasis (Mills & Moolenaar,
2003), as well as in angiogenesis (Fotopoulou et al., 2010; Tanaka et
al., 2006; van Meeteren et al., 2006). As such, ATX holds great
promise as a therapeutic target (Albers et al., 2010).
ATX harbours a central catalytic domain that is similar to bacterial
phosphodiesterases and alkaline phosphatases. This domain is
ﬂanked N-terminally by two Cys-rich somatomedin B-like (SMB)
domains and C-terminally by a nuclease-like domain. The intact
secreted protein is required for activity and glycosylation has been
shown to be crucial for function (Jansen et al., 2007). We therefore set
out toproduce ATX in sufﬁcient amounts for crystallographic studies.
Protocols for the overexpression of secreted proteins in mamma-
lian cell lines and amounts suitable for crystallographic studies have
been established as part of the SPINE consortium (Aricescu et al.,
2006). We adapted these protocols and extended them to the use of
stably transfected cell lines.
Although ATX was easy to crystallize once produced in homo-
genous form and good quantity, we could only obtain plate-like
microcrystals. Despite older (Cusack et al., 1998; Perrakis et al., 1999)
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et al., 2008; Sanishvili et al., 2008; Schneider, 2008) in micro-
crystallography, data collection from plate-like microcrystals
presented a challenge, which we discuss here.
2. Experimental procedures and results
2.1. Construction of a stable cell line expressing ATX
An rATX construct retaining only one glycosylation site essential
for activity (Jansen et al., 2007) was ampliﬁed by PCR from plasmid
DNA (using 50-TGGTACCGCCACCATGGCAAGACAAGGCTG-
TCTC-30 and 50-ACCGGTAATCTCGCTCTCATATGT-30 primers)
and the reaction product was cut with Asp718I and AgeI restriction
enzymes and cloned into the plasmid pcDNA3.1/V5-His (Invitrogen)
in order to introduce a C-terminal His6 tag. The rATX-His gene was
ampliﬁed by PCR (using 50-TGGTACCGCCACCATGGCAAGAC-
AAGGCTGTCTC-30 and 50-GGATCCTCAATGGTGATGGTGA-
TG-30 primers), cut with Asp718I and PinAI restriction enzymes and
cloned into the plasmid pcDNA5/FRT. Restriction digests were
performed for 1 h at 310 K. PCR reactions were performed using Pfu
polymerase (Stratagene; catalogue No. 600353-51) in 50 ml reaction
volumes using 30 PCR cycles (denaturation at 369 K for 30 s,
annealing at 328 K for 30 s and 345 K for 120 s). All other conditions
used were according to the manufacturer’s instructions and used the
reaction buffers supplied by the manufacturer. The ﬁnal clone was
veriﬁed by sequencing.
HEK 293 Flp-In cells (Invitrogen) were grown in 10 cm tissue-
culture dishes in DMEM medium (Invitrogen; catalogue No. 41966-
052) containing 10% FCS (Sigma; catalogue No. 8200496835) and
100 mgm l
 1 Zeocin (Invitrogen; catalogue No. 45-0430). On the day
of transfection, the cells (80–90% conﬂuent) were washed with
medium without Zeocin and co-transfected with 2 mg pcDNA5/FRT-
rATX-His and 18 mg pOG44 (Invitrogen; catalogue No. K6010-01)
using lipofectamine (Invitrogen; catalogue No. 18324012). Next day,
the cells were washed using fresh medium without antibiotics. The
following day, the cells were split to  20% conﬂuence in fresh
medium containing 100 mgm l
 1 hygromycin B (Invitrogen; catalogue
No. 10687-010) and allowed to grow for approximately 10 d until foci
could be identiﬁed. Six foci were picked and expanded in T175 tissue-
culture ﬂasks in DMEM medium containing 10% FCS and
100 mgm l
 1 hygromycin B to verify resistance in hygromycin B. The
cells were ﬂash-frozen in liquid nitrogen for future use.
2.2. Large-scale expression
For large-scale expression, cells were ﬁrst grown in T175 tissue-
culture ﬂasks in DMEM medium containing 10% FCS and
100 mgm l
 1 hygromycin B. The cells were grown to 80–90% conﬂu-
ence, washed twice with fresh DMEM medium and transferred to
roller bottles (Greiner Bio-One; catalogue No. 681070). Typically, a
single T175 ﬂask was used to inoculate one roller bottle and the cells
were cultured for 4 d after transfer into 125 ml DMEM containing
10% FCS. The medium was changed to 125 ml DMEM supplemented
with 2 mM glutamate (GIBCO; catalogue No. 25030-123) and the
cells were left to express protein for 4 d. The medium was collected
and the cells were supplemented with fresh medium and left to
express protein for a further 4 d.
2.3. Purification of secreted ATX
The medium was collected and ﬁltered through a 0.45 mm bottle-
top ﬁlter. The ﬁltered medium was subsequently applied at a ﬂow rate
of 10–15 ml min
 1 onto an  10 ml POROS-20 MC column that had
been pre-loaded with Ni
2+. The column was washed with eight to ten
column volumes of buffer A (20 mM Tris–HCl pH 8.0, 150 mM NaCl
and 10–20 mM imidazole). The protein was eluted with a short (2–3
column volumes) linear gradient to buffer A containing 750 mM
imidazole. The rATX fractions were mostly pure, with the exception
of an  200 kDa band. To remove this band, the pooled fractions were
concentrated and applied onto a Superose 6 10/30 size-exclusion
column in buffer A. rATX eluted as a single symmetric peak at a
column volume corresponding to a monomer of  100 kDa. The peak
fractions were pooled and concentrated to  3–4 mg ml
 1 for crys-
tallization.
Concentration posed a serious practical problem, as rATX would
‘stick’ in most commonly used centrifugal ﬁlters, preventing con-
centration. We initially resorted to dialysis against 30% PEG 10 000
to concentrate the protein. However, the use of Ultra-15 (Amicon;
10 kDa molecular-weight cutoff) centrifugal ﬁlters allowed more
efﬁcient concentration later in the course of the project. Preparation
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Table 1
Sample information.
Crystal 1 Crystal 2 Crystal 3
Macromolecule details
Mass (Da) 98000 98000 98000
Source organism Rattus norvegicus Rattus norvegicus Rattus norvegicus
Crystallization and crystal data
Crystallization method Sitting-drop vapour diffusion Sitting-drop vapour diffusion Sitting-drop vapour diffusion
Temperature (K) 293 293 293
Crystal-growth time (d) 4–5 4–5 2
Crystallization solutions
Macromolecule 4 ml 3–4 mg ml
 1 rATX, 150 mM NaCl,
20 mM Tris–HCl pH 8
4 ml 3–4 mg ml
 1 rATX, 150 mM NaCl,
20 mM Tris–HCl pH 8
200 nl 3–4 mg ml
 1 rATX, 150 mM NaCl,
20 mM Tris–HCl pH 8
Precipitant 5 ml 20%(w/v) polyethylene glycol 6000,
100 mM potassium citrate,
100 mM MIB buffer pH 8.5
5 ml 18–22%(w/v) polyethylene glycol 6000,
100 mM potassium citrate,
100 mM MIB buffer pH 8.5
100 nl 20%(w/v) polyethylene glycol 3350,
100 mM bis-tris propane pH 6.5–8.5
Additive 1 ml1M MEGA-8/10 1 ml1M MEGA-8/10 20–200 mM sodium/potassium phosphate
Crystal data
Crystal dimensions (mm)  100   50   1  150   30   1  200   30    1
Matthews coefﬁcient VM (A ˚ 3 Da
 1) 2.38 2.38 2.38
Solvent content (%) 48 48 48
Unit-cell data
Crystal system, space group Orthorhombic, P212121 Orthorhombic, P212121 Orthorhombic, P212121
Unit-cell parameters (A ˚ ,  ) a = 95.3, b = 121.8, c = 158.4,  =  =  =9 0 a = 96.2, b = 121.7, c = 160.0,  =  =  =9 0 a = 95.4, b = 120.2, c = 157.1,  =  =  =9 0
No. of molecules in unit cell Z 222of eight roller bottles typically allowed 2–3 mg of protein to be
produced.
2.4. Crystallization
rATX was initially crystallized by vapour diffusion in nanodrops
using the protocols summarized in Newman et al. (2005). Crystals in
the shape of microscopic plates appeared in many conditions from
thePACTscreen(manufactured byQiagenanddescribedbyNewman
et al., 2005). All conditions that produced initial hits contained PEG
by deﬁnition and, given the highly redundant nature of the PACT
screen, hits appeared in about ten drops; the conditions giving the
best crystals were B5 [0.1 M MIB buffer pH 8, 25%(w/v) PEG 1500],
B6 [0.1 M MIB buffer pH 9, 25%(w/v) PEG 1500] and E11 [0.2 M
sodium citrate, 20%(w/v) PEG 3350]. Various attempts to improve
the size of these crystals failed; the largest crystals that we were able
to grow using these conditions were plates of several tens of a
micrometre across but of sub-micrometre thickness at best.
After additive screening, octanoyl-N-methylglucamide (MEGA-8)
appeared to have a positive effect on crystal size. Crystallization in
very large drops with a total volume of 10 ml produced plate-like
crystals of excellent morphology with a smallest dimension estimated
to be just above 1 mm (Table 1).
Following optimization of the rATX puriﬁcation protocol, addi-
tional optimization showed that micrometre-thick crystals could be
grown, without the need for detergent or large drops, in standard
SBS-format crystallization plates with drops of 300 nl total volume
using a Mosquito liquid-handling robot. The presence of phosphate
ions at a concentration of 20–200 mM was crucial for the formation of
these crystals, which appeared over a wide pH range and had a
morphology that was identical to those produced in the presence of
detergent (Table 1). These crystals formed with or without seeding,
although seeding accelerated crystal formation.
In both crystallization protocols a higher concentration of protein
correlated well with increased crystal size. However, the practical
yields of protein did not allow concentration above a certain limit,
which was maximally  5m gm l
 1.
Although we successfully produced SeMet-substituted protein in
the stable HEK 293 cell line, yields were signiﬁcantly lower owing
to the toxicity of selenomethionine, which precluded sufﬁcient con-
centration of the protein for the growth of crystals of size similar to
those of the native protein.
Crystals were transferred to a solution typically containing 20–25%
glycerol in addition to the mother liquor and mounted in loops. All
crystals were vitriﬁed by plunging them in liquid nitrogen, mounted in
SPINE pins and transferred into SPINE/ESRF pucks for shipment
and data collection at the synchrotron (Beteva et al., 2006). During
crystallization communications
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Figure 1
The crystals used for data collection. (a) ‘Crystal 2’ exposed at the SLS in the crystallization drop. (b) ‘Crystal 3’ exposed at Diamond as seen at the beamline mounted in a
loop and ﬂash-frozen.
Table 2
Data-collection statistics from individual crystals.
Values in parentheses are for the outer shell and those in square brackets are for that around 3.2 A ˚ resolution (shown for better appreciation of the data-completeness issues).
Crystal 1 Crystal 2 Crystal 3
Source SLS X06SA SLS X06SA Diamond I24
X-ray beam size (mm) 10   10 40   100 8   8/15   20/30   50
Wedges collected ( ) 0–30/40–60/70–90 0–25 0–10/10–50/60–100
Crystal-to-detector distance (mm) 300 520.0 535.9
Exposure time (s) 1 1 2
Rotation range per image (
o) 1.0 0.25 1.0
Diffraction protocol Single wavelength Single wavelength Single wavelength
Wavelength (A ˚ ) 0.933 0.978 0.978
Detector MAR 225 CCD Pilatus 6M Pilatus 6M
Temperature (K) 100 100 100
Resolution range (A ˚ ) 50.0–2.6 (2.74–2.6) [3.36–3.11] 50.0–2.6 (2.74–2.6) [3.36–3.11] 50.0–2.6 (2.74–2.6) [3.36–3.11]
No. of unique reﬂections 46204 (3355) 30282 (3567) 48210 (3048)
No. of observed reﬂections 120917 (6162) 42546 (4112) 131664 (3748)
Completeness (%) 80.5 (40.2) [97.5] 52.9 (43.2) [58.8] 86.8 (38.6) [97.8]
Multiplicity 2.6 (1.8) [2.7] 1.4 (1.2) [1.4] 2.7 (1.2) [3.2]
hI/(I)i 4.9 (1.6) [3.1] 4.0 (1.4) [3.8] 4.5 (1.3) [3.7]
Rmerge 0.180 (0.511) [0.371] 0.106 (0.299) [0.180] 0.186 (0.364) [0.300]
Data-processing software MOSFLM/SCALA XDS/SCALA XDS/SCALAthe course of about two years, a couple of thousand crystals were
mounted and about a third of these attempts gave single crystals in
the loop. Roughly 500 crystals were tested for diffraction. About 30
data sets were collected in total and the best data are presented in this
paper. The crystals used to collect these data are shown in Fig. 1.
2.5. Collection of diffraction data and analysis
We discuss the measurement of three data sets: two were collected
from crystals grown from very large crystallization drops (10 ml), one
using a microbeam (10   10 mm) and one using a typical sized beam
(40   100 mm); the third data set was collected from crystals grown in
small crystallization drops (0.3 ml).
2.5.1. SLS data collection with a microdiffractometer. A good-
quality crystal was obtained after extensive screening on the SLS
X06SA beamline (PX1) in a setup equipped with the EMBL/ESRF
microdiffractometer (Perrakis et al., 1999) and a 10 mm beam-deﬁning
aperture. Based on our experience with previous crystals, we knew
that they had a limited lifetime. The longer dimension of the crystal
was oriented along the rotation axis to allow translation between
successive wedges and to minimize radiation damage. The ﬁrst wedge
of 30  was collected ‘edge-on’, while the last 20  were collected ‘face-
on’. It can be seen from Figs. 2(a) and 2(b) that in the ‘edge-on’
orientation diffraction is strong but the spots are imperfect owing to
crystal imperfections along the long plate axis fully bathed in the
beam, while in the ‘face-on’ orientation diffraction is signiﬁcantly
weaker but the spots are very small and round-shaped with clear
edges since only a very limited volume of the crystal is exposed. This
strategy resulted in a data set of good quality; the spot intensities
were integrated in MOSFLM using the ‘RESOLUTION CUTOFF
1.0’ keyword that limits the radial integration area in each image to
the resolution bin in which the average I/(I) falls below 1.0. The
resulting data set was complete to about 3.2 A ˚ resolution and
contained useful data to 2.6 A ˚ resolution (Table 2).
2.5.2. SLS data collection with a ‘typical’ beam and a Pilatus
detector. At a later data-collection trip, a crystal of similar quality but
possibly exceeding 1 mm in thickness was identiﬁed. At this time we
were using the SLS ‘high-resolution diffractometer’ with a beam of
approximately 40   100 mm and we were aware that we were lacking
‘face-on’data from the previous data set. We were only able to collect
25  of data before the crystal suffered from radiation damage. The
data-quality statistics for this  50% complete data set (Table 2)
demonstrated that the crystal plates were of excellent quality, with
minimal distortion around their surface. We observed that our crystal
could withstand a higher X-ray dose in the shutter-less data-collection
mode enabled by the Pilatus 6M detector (Broennimann et al., 2006),
than in the same beam with the same exposure and a normal CCD
detector.
2.5.3. A combined native data set and obstacles in collecting an
SeMet data set. Combining the above data, we obtained a data set to
2.6 A ˚ resolution (Table 3). This data set had improved completeness,
speciﬁcally in the higher resolution shell (69.7% compared with
40.2%), owing to the contribution of the 25  wedge contributed by
the second crystal in the ‘face-on’ orientation. Although this region
was collected with the microbeam for the ﬁrst crystal, these ‘face-on’
images contained diffraction to much lower resolution.
This data set was used for molecular replacement using a bacterial
phosphodiesterase domain (Zalatan et al., 2006) homologous to one
of the four domains of ATX (with 28% identity) as a search model.
Although a clear solution was easily obtained in Phaser (McCoy et al.,
2007), efforts to reﬁne this model and complete the structure were
unsuccessful. The free R factor did not decrease and the electron-
density maps did not show any features for either the differences
between the bacterial and mammalian sequences or the three
domains that were not present in the search model ( 60% of the
molecule).
Therefore, we focused our attention on obtaining an SeMet data
set, a quest that failed. This effort was hampered by a lack of the
crystallization communications
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Figure 2
Setups for diffraction data collection (with the beam shown in green and the crystal in yellow) and the corresponding sample diffraction images, illustrating the differences
bwtween the (a) ‘edge-on’and (b) ‘face-on’ orientations. The sizes of the beam and the crystal in the diagram are approximate.SeMet protein required to obtain sufﬁciently large crystals. The
crystals did not exceed 1 mm in thickness and the other two plate
dimensions were typically less than 40 mm. We were thus unable to
collect a redundant and high-quality data set even to a modest
resolution of about  3.5 A ˚ . Minimizing the exposure in order to
increase the lifetime led to data that were too weak. While the SAD
data that we were able to collect from a few small crystals were of
reasonable quality, the redundancy was too low (anomalous redun-
dancy of 3.7 for our best data set) to generate a sufﬁcient anomalous
signal-to-noise ratio (the anomalous correlation dropped below 30%
at  7A ˚ resolution for the best data set). Attempts to combine data
sets from different crystals did not produce an improved anomalous
signal-to-noise ratio. Soaking experiments proved physically difﬁcult
to perform owing to the small crystal size and did not result in usable
data.
2.5.4. Data collection on the Diamond I24 microfocus beamline
using variable beam size. During our attempts to obtain an SeMet
crystal from nanodrops for diffraction studies, we produced native
crystals with some alterations in the crystallization protocol (Table 1).
The size of these crystals was similar to that of the previous crystals,
despite being grown from nanodrops, and they were used to test data-
collection protocols for subsequent SeMet data collection at I24, a
tuneable microfocus beamline that at the time was in the late stages
of commissioning at Diamond Light Source. The versatile optical
design of I24 (Evans et al., 2006) allows the use of three beam sizes, a
microbeam of 8   8 mm, a medium-sized beam of 15   20 mm and a
larger 30   50 mm beam (v   h). As changes in beam size are
achieved via the refocusing of mirrors rather than through the use of
apertures or deﬁning slits, the total ﬂux at the sample position of
 10
12 photons s
 1 is preserved for each of these different-sized
beams. I24 was designed speciﬁcally to allow the matching of X-ray
beam properties to sample properties and in the simplest case this
means that where possible the beam size is matched to the projected
dimensions of the crystal along the beam axis.
For these crystals the beam size was adjusted accordingly for
different crystal orientations and this allowed a data set of good
quality and completeness to be collected from a single microcrystal.
3. Discussion
3.1. Protein production in stably transfected mammalian cells for
crystallographic studies
We have expressed a mammalian glycoprotein in stably transfected
HEK 293 cells. Producing a stable cell line with the Flp-In system is
straightforward and allows the routine production of protein without
the need for transfection, minimizing the routine costs (the cost of
large DNA preparations for transfection of large volumes of cell
culture as well as the cost of transfection media are eliminated) as
well as the uncertainty and heterogeneity of transfection success.
Production in roller bottles allows a straightforward scale-up of the
procedure at a low cost since the use of FCS is eliminated in the ﬁnal
stages. Loading of the medium containing the secreted protein onto a
fast ﬂow resin allowed much faster protein puriﬁcation without prior
concentration. Additionally, screening commercial products to ﬁnd a
device that allowed centrifugal protein concentration was important
in order to be able to concentrate the protein further, faster and in
smaller volumes and enabled more efﬁcient crystallization screening.
Finally, we were able to use nanocrystallization vapour-diffusion
experiments in 0.3 ml drops, yielding excellent quality small crystals
similar to these obtained in 10 ml drops. This is another case in a
largely anecdotal line of evidence that argues that drop size does not
correlate well with crystal size and quality.
3.2. Limitations of using micrometre-thick plate-like crystals
Crystallization screening using the vapour-diffusion method in
nanodrops allowed the production of very small plate-like crystals.
Subsequent optimization in very large drops (10 ml total) in the
presence of detergent or subsequently also in nanodrops (0.3 ml)
allowed the formation of micrometre-thick crystals that were suitable
for collecting diffraction data to 2.6 A ˚ resolution.
Despite recent excellent advances in instrumentation, the manip-
ulation of very thin plate-shaped crystals presents clear challenges
that need to be resolved. Since plates have a preferred orientation in
mounting loops, they are invisible in ‘edge-on’ orientation, calling for
grid-scan procedures (Aishima et al., 2010; Bowler et al., 2010; Song et
al., 2007), such as that available at I24, to determine the ideal centring
by diffraction in that orientation.
Furthermore, while a microbeam is ideal for collecting data in the
‘edge-on’ orientation, a larger size beam is preferable ‘face-on’, as
illustrated in Fig. 3. As an example, consider two possible beam sizes,
a microbeam of 10   10 mm and a more common beam size of
100   50 mm, being used to measure data from a typical rATX crystal
of dimensions 100   50   1 mm. Clearly, neither situation is optimal.
In the ‘edge-on’ orientation a microbeam is best (Fig. 3a). With such a
crystallization communications
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Figure 3
A schematic diagram illustrating the beneﬁts and problems of small and large beams (shown in green) for plate-like crystals (shown in yellow): (a) thin plate ‘edge-on’ with
microbeam (good), (b) thin plate ‘face-on’ with microbeam (bad), (c) thin plate ‘edge-on’ with large beam (bad) and (d) thin plate ‘face-on’ with large beam (good).
Table 3
Data-collection statistics for the combined data set.
Values in parentheses are for the outer shell and those in square brackets are for that
around 3.2 A ˚ resolution.
Crystals 1 + 2
Source SLS X06SA
Resolution range (A ˚ ) 50.0–2.6 (2.74–2.6) [3.36–3.11]
No. of unique reﬂections 52092 (5747)
No. of observed reﬂections 162655 (10544)
Completeness (%) 91.0 (69.7) [99.0]
Redundancy 3.1 (1.8) [3.4]
hI/(I)i 7.7 (1.5) [4.1]
Rmerge 0.191 (0.488) [0.359]
Data-processing software MOSFLM/SCALAthin crystal, the maximal volume is exposed in the ‘edge-on’ orien-
tation: for the dimensions given above, in this orientation a volume of
 500 mm
3 is exposed (1 mm crystal thickness   10 mm of crystal along
the long axis across the beam, which is limited by the beam size,
  50 mm of the crystal’s other long axis along the beam). In the ‘face-
on’ orientation only  100 mm
3 of crystal volume would be exposed to
the micro-beam (Fig. 3b;1mm crystal thickness   10 mm   10 mmo f
crystal limited by the beam size in both long crystal dimensions).
However, after a few degrees of rotation one can use a larger beam
and ﬁnally in the ‘face-on’ orientation a large beam matching the
plate size is best suited (Fig. 3d;1mm crystal thickness   100 mm  
50 mm of crystal along the long axes across the beam) and would
result in  5000 mm
3 of crystal being exposed. However, the large
beam would result in a too high a background in the ‘edge-on’
orientation, as effectively only 2% of the beam would hit the crystal
(Fig. 3c). In our opinion, variable beam sizes in which the beam size
adapts dynamically during data collection could have possibly
improved data collection from these crystals.
The availability of a variable beam size at I24 allowed data
collection from a single plate-shaped crystal even though only three
discrete sizes were offered at the time. Use of the grid-scan technique
to centre the ‘edge-on’ orientation and the subsequent use of variable
beam sizes resulted in data being measured from a single crystal that
were of a quality comparable to those obtained from two crystals on
the SLS X06SA beamline using two different microdiffractometers.
At the time of these experiments only three discrete beam sizes were
available at I24, but the design goal for this beamline is continuous
and independent variability of beam size in both directions so as to
permit optimal adaptation of the beam characteristics to the size and
orientation of the sample.
We argue here that an X-ray beam that could be changed in size
every few degrees throughout data collection or software that would
allow three-dimensional data-collection strategies utilizing all of
the volume of thin plate-shaped crystals could allow more efﬁcient
data collection. If the available beam size matches the smallest crystal
dimension, microcrystals, in a way, present the lesser challenge for
data collection: the choice is limited to a single volume. Needle-like
crystals provide an additional dimension of complexity: to utilize the
whole crystal volume a one-dimensional ‘scan’ across the length of
the needle is desirable (Flot et al., 2010) using a ﬁxed beam size.
However, plate-like crystals create a more complex challenge: to
utilize the crystal volume efﬁciently two-dimensional scanning would
be needed together with variation of the beam size dependent on
crystal orientation. Such procedures may possibly have allowed data
collection from a single SeMet crystal of rATX, which might in turn
have enabled a more accurate recording of the anomalous signal to
facilitate structure solution. In retrospect, the main obstacle to
structure solution from these data was the size of the crystals rather
than the diffraction limit or other basic problems.
Determination of the crystal structure of rATX was made possible
by the addition of two components to the precipitating solution of our
‘basic’ crystallization protocol (Day et al., 2010).
JH and AP thank Clemens Schulze-Briese and the scientists at SLS
for their expert help and access to the SLS PX1 beamline for the
duration of this project, Jonathan Grimes for help in data collection
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